Inventor

BRIEM HANS

DE53 patents

⚠️ This page may combine multiple inventors who share the name “BRIEM HANS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRIEM HANS

Bayer Pharma AG

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

Substituted benzylpyrazoles

Heteroaryl substituted pyrazoles

Heteroaryl substituted pyrazoles

4H-pyrrolo[3,2-C]pyridin-4-one derivatives

Substituted triazolopyridines

Benzyl substituted indazoles as BUB1 inhibitors

Heteroarylbenzimidazole compounds

1H-pyrrol-3-amines

3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones

3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones

BOEHRINGER INGELHEIM KG

Neurokinin antagonists

Neurokinin antagonists

Neurokinin antagonists

Arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds

Neurokinin antagonists

Neurokinin antagonists

Arylglycinamide derivatives and pharmaceutical compositions containing these compounds

Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

Arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds

Method of treating depression with arylglycinamide derivatives

BOEHRINGER INGELHEIM PHARMA

Trisubstituted pyrimidines

Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity

Arylysulphonamide-substituted benzimidazoles having tryptase-inhibiting activity

β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions

Arylsulphonamide-substituted benzimidazoles having tryptase-inhibiting activity

Carboxamide-substituted benzimidazoles having tryptase-inhibiting activity

N-(5-phenyl-tetrahydrofuranyl)methyl- and N-(6-phenyl-tetrahydropyranyl)methyl-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols

BAYER SCHERING PHARMA AG

Macrocyclic pyrimidines, their production and use as pharmaceutical agents

Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs

Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same

BAYER IP GMBH

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

Substituted benzylpyrazoles

Imidazopyridazines as Akt kinase inhibitors

Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases

SCHULZE VOLKER

Substituted triazolopyridines

Triazolopyridines

SCHERING AG

Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents

Bärfacker Lars

Imidazopyridazines as Akt kinase inhibitors

MICHELS MARTIN

Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof

HARTUNG INGO

Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same